Biosimilars in Gastroenterology- An Important Moment in the Treatment of Inflammatory Bowel Diseases

International Journal of Gastroenterology Disorders & Therapy
doi 10.15344/2393-8498/2016/124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Graphyonline Publications PVT, Ltd.

Related search

Biosimilars: Concept, Current Status, and Future Perspectives in Inflammatory Bowel Diseases

Intestinal Research
Gastroenterology
2020English

Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

The Role of Biosimilars in the Treatment of Rheumatic Diseases

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

The Role of Biosimilars in the Treatment of Rheumatic Diseases

Clinical pharmacology and therapy
2018English

Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

BioDrugs
MedicineBiotechnologyPharmacology
2016English

Natural Product-Derived Drugs for the Treatment of Inflammatory Bowel Diseases

Intestinal Research
Gastroenterology
2014English

Biosimilars in the Treatment of Rheumatic Diseases: Pro Et Contra

Clinical pharmacology and therapy
2019English

N-3 Fatty Acids for the Treatment of Inflammatory Bowel Diseases

Proceedings of the Nutrition Society
MedicineNutritionDietetics
2002English

Changes of the Cytokine Profile in Inflammatory Bowel Diseases

World Journal of Gastroenterology
MedicineGastroenterology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy